VTD (velcade, thalidomide, dexamethasone) as primary therapy for newly-diagnosed multiple myeloma.

被引：0
|
作者：
Alexaman, R [1 ]
Wang, LM [1 ]
Weber, DM [1 ]
Delasalle, KB [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
210
引用
收藏
页码：64A / 64A
页数：1
相关论文
共 50 条
  • [21] Thalidomide alone or with dexamethasone for multiple myeloma.
    Weber, DM
    Gavino, M
    Delasalle, K
    Rankin, K
    Giralt, S
    Alexanian, R
    BLOOD, 1999, 94 (10) : 604A - 604A
  • [22] Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
    Rajkumar, SV
    Hayman, S
    Gertz, MA
    Dispenzieri, A
    Lacy, MQ
    Greipp, PR
    Geyer, S
    Iturria, N
    Fonseca, R
    Lust, JA
    Kyle, RA
    Witzig, TE
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) : 4319 - 4323
  • [23] Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
    Huston, Alissa
    Brown, Jason
    Roodman, G. David
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (12) : 1616 - 1616
  • [24] CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE (CTD) AS INITIAL THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Vasquez, J.
    Ruiz, R.
    Aliaga, K.
    Valencia, F.
    Enriquez, D.
    Palacios, V.
    Quintana, S.
    Casanova, L.
    HAEMATOLOGICA, 2016, 101 : 798 - 798
  • [25] COMBINATION THERAPY WITH INTERFERON-DEXAMETHASONE FOR NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA
    DIMOPOULOS, MA
    WEBER, D
    DELASALLE, KB
    ALEXANIAN, R
    CANCER, 1993, 72 (09) : 2589 - 2592
  • [26] Sequential VAD (vincristine, adriamycin, dexamethasone) and VTD (VELCADE®, thalidomide, dexamethasone) induction followed by high-dose therapy with autologous stem cell transplantation and maintenance treatment with VELCADE for newly diagnosed multiple myeloma:: Interim results of phase II trial
    Yoon, Sung-Soo
    Kim, Hye Jin
    Lee, Dong Soon
    Eom, Hyeon Seok
    Jang, Jun Ho
    Chung, Ju Seup
    Kang, Hye Jin
    Kim, Cheol Soo
    Kim, Kihyun
    Lee, Jae Hoon
    Lee, Sang Jae
    Min, Yu Hong
    Seong, Chu Myong
    Sohn, Sang Kyun
    Suh, Cheolwon
    Won, Jong Ho
    BLOOD, 2007, 110 (11) : 290A - 290A
  • [27] Newly diagnosed multiple myeloma.
    Weber D.M.
    Current Treatment Options in Oncology, 2002, 3 (3) : 235 - 245
  • [28] Thalidomide plus dexamethasone for newly diagnosed myeloma
    Lindsey, H
    LANCET ONCOLOGY, 2002, 3 (12): : 711 - 711
  • [29] Thalidomide/Dexamethasone (TD) Versus Bortezomib (Velcade)/Thalidomide/Dexamethasone (VTD) Versus VB
    Rosinol, L.
    Cibeira, M. T.
    Martinez, J.
    Mateos, M. V.
    Terol, M. J.
    de la Rubia, J.
    Palomera, L.
    de Arriba, F.
    Oriol, A.
    Amor, A. A.
    Besalduch, J.
    de Paz, R.
    Garcia-Larana, J.
    Diaz-Mediavilla, J.
    Sureda, A.
    Lahuerta, J. J.
    San Miguel, J.
    Blade, J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S26 - S26
  • [30] Thalidomide and dexamethasone for newly diagnosed multiple myeloma: Is this really the standard of care?
    Nabhan, Chadi
    Bitran, Jacob D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2967 - 2968
12345